Research strategy
Our Research Strategy sets out how we will build on cross-disciplinary opportunities to maximise our research impact, attract the necessary funding to develop our state-of the-art facilities, and ensure an academic environment that supports our exceptional people.
Objectives
Over the next five years we will:
- Deliver high impact research that generates new insights into the causes, prevention and treatment of diseases
- Drive interdisciplinary cross-cutting themes to foster collaboration, shared platforms and capabilities
- Lead clinical trials of new treatments that impact on diagnosis and patient care
- Develop new technologies in experimental and clinical imaging that enable new research insights and clinical translation
- Develop IP leading to new spinouts and licence deals
structure
These objectives will be delivered through two main sections (Cardiovascular & Metabolic Medicine and Molecular Medicine), and the three cross-cutting research themes (Metabolism in Molecular Medicine, Cell and Gene Therapy, and AI and Medical Big Data.
The success of RDM's research strategy will be supported by six key enablers: People, Collaboration, Capabilities, Translation & Innovation, Funding and Estates.
